QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ghislain, J. Articles by Frain, M. Search for Related Content PubMed PubMed Citation Articles by Ghislain, J. Articles by Frain, M. Social Bookmarking                         What's this?

Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development

¹ Unité 368 de l’Institut National de la Santé et de la Recherche Médicale, Ecole Normale Supérieure, 46 rue d’Ulm, 75230 Paris Cedex 05, France
² Department of Cell Biology and Genetics, Erasmus University Rotterdam, P.O. Box 1738, 3000DR Rotterdam, The Netherlands

*Author for correspondence (e-mail: charnay{at}wotan.ens.fr)

Accepted 16 October 2001

In Schwann cells (SC), myelination is controlled by the transcription factor gene Krox20/Egr2. Analysis of cis-acting elements governing Krox20 expression in SC revealed the existence of two separate elements. The first, designated immature Schwann cell element (ISE), was active in immature but not myelinating SC, whereas the second, designated myelinating Schwann cell element (MSE), was active from the onset of myelination to adulthood in myelinating SC. In vivo sciatic nerve regeneration experiments demonstrated that both elements were activated during this process, in an axon-dependent manner. Together the activity of these elements reproduced the profile of Krox20 expression during development and regeneration. Genetic studies showed that both elements were active in a Krox20 mutant background, while the activity of the MSE, but likely not of the ISE, required the POU domain transcription factor Oct6 at the time of myelination. The MSE was localised to a 1.3 kb fragment, 35 kb downstream of Krox20. The identification of multiple Oct6 binding sites within this fragment suggested that Oct6 directly controls Krox20 transcription. Taken together, these data indicate that, although Krox20 is expressed continuously from 15.5 dpc in SC, the regulation of its expression is a biphasic, axon-dependent phenomenon involving two cis-acting elements that act in succession during development. In addition, they provide insight into the complexity of the transcription factor regulatory network controlling myelination.

Key words: Krox20/Egr2, Oct6/Tst1/SCIP/Pou3f1, Schwann cell, Boundary cap, Myelination, Transcriptional regulation, Peripheral nervous system

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				S.-C. Kao, H. Wu, J. Xie, C.-P. Chang, J. A. Ranish, I. A. Graef, and G. R. Crabtree Calcineurin/NFAT Signaling Is Required for Neuregulin-Regulated Schwann Cell Differentiation Science, January 30, 2009; 323(5914): 651 - 654. [Abstract] [Full Text] [PDF]

				A. Desmazieres, L. Decker, J.-M. Vallat, P. Charnay, and P. Gilardi-Hebenstreit Disruption of Krox20-Nab Interaction in the Mouse Leads to Peripheral Neuropathy with Biphasic Evolution J. Neurosci., June 4, 2008; 28(23): 5891 - 5900. [Abstract] [Full Text] [PDF]

				E. J. Ryu, J. Y. T. Wang, N. Le, R. H. Baloh, J. A. Gustin, R. E. Schmidt, and J. Milbrandt Misexpression of Pou3f1 Results in Peripheral Nerve Hypomyelination and Axonal Loss J. Neurosci., October 24, 2007; 27(43): 11552 - 11559. [Abstract] [Full Text] [PDF]

				S. Schreiner, F. Cossais, K. Fischer, S. Scholz, M. R. Bosl, B. Holtmann, M. Sendtner, and M. Wegner Hypomorphic Sox10 alleles reveal novel protein functions and unravel developmental differences in glial lineages Development, September 15, 2007; 134(18): 3271 - 3281. [Abstract] [Full Text] [PDF]

				V. Zujovic, C. Bachelin, and A. Baron-Van Evercooren Remyelination of the Central Nervous System: A Valuable Contribution from the Periphery Neuroscientist, August 1, 2007; 13(4): 383 - 391. [Abstract] [PDF]

				S. E. LeBlanc, R. M. Ward, and J. Svaren Neuropathy-Associated Egr2 Mutants Disrupt Cooperative Activation of Myelin Protein Zero by Egr2 and Sox10 Mol. Cell. Biol., May 1, 2007; 27(9): 3521 - 3529. [Abstract] [Full Text] [PDF]

				L. Decker, C. Desmarquet-Trin-Dinh, E. Taillebourg, J. Ghislain, J.-M. Vallat, and P. Charnay Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J. Neurosci., September 20, 2006; 26(38): 9771 - 9779. [Abstract] [Full Text] [PDF]

				D. Chomette, M. Frain, S. Cereghini, P. Charnay, and J. Ghislain Krox20 hindbrain cis-regulatory landscape: interplay between multiple long-range initiation and autoregulatory elements Development, April 1, 2006; 133(7): 1253 - 1262. [Abstract] [Full Text] [PDF]

				S. E. LeBlanc, S.-W. Jang, R. M. Ward, L. Wrabetz, and J. Svaren Direct Regulation of Myelin Protein Zero Expression by the Egr2 Transactivator J. Biol. Chem., March 3, 2006; 281(9): 5453 - 5460. [Abstract] [Full Text] [PDF]

				S. Wissmuller, T. Kosian, M. Wolf, M. Finzsch, and M. Wegner The high-mobility-group domain of Sox proteins interacts with DNA-binding domains of many transcription factors. Nucleic Acids Res., January 1, 2006; 34(6): 1735 - 1744. [Abstract] [Full Text] [PDF]

				E. Denarier, R. Forghani, H. F. Farhadi, S. Dib, N. Dionne, H. C. Friedman, P. Lepage, T. J. Hudson, R. Drouin, and A. Peterson Functional Organization of a Schwann Cell Enhancer J. Neurosci., November 30, 2005; 25(48): 11210 - 11217. [Abstract] [Full Text] [PDF]

				R. P. Friedrich, B. Schlierf, E. R. Tamm, M. R. Bosl, and M. Wegner The Class III POU Domain Protein Brn-1 Can Fully Replace the Related Oct-6 during Schwann Cell Development and Myelination Mol. Cell. Biol., March 1, 2005; 25(5): 1821 - 1829. [Abstract] [Full Text] [PDF]

				M. Jaegle, M. Ghazvini, W. Mandemakers, M. Piirsoo, S. Driegen, F. Levavasseur, S. Raghoenath, F. Grosveld, and D. Meijer The POU proteins Brn-2 and Oct-6 share important functions in Schwann cell development Genes & Dev., June 1, 2003; 17(11): 1380 - 1391. [Abstract] [Full Text] [PDF]

				J. Ghislain, C. Desmarquet-Trin-Dinh, P. Gilardi-Hebenstreit, P. Charnay, and M. Frain Neural crest patterning: autoregulatory and crest-specific elements co-operate for Krox20 transcriptional control Development, March 1, 2003; 130(5): 941 - 953. [Abstract] [Full Text] [PDF]

				J. R. Bermingham Jr, S. Shumas, T. Whisenhunt, E. E. Sirkowski, S. O'Connell, S. S. Scherer, and M. G. Rosenfeld Identification of Genes That Are Downregulated in the Absence of the POU Domain Transcription Factor pou3f1 (Oct-6, Tst-1, SCIP) in Sciatic Nerve J. Neurosci., December 1, 2002; 22(23): 10217 - 10231. [Abstract] [Full Text] [PDF]